Please assess the completion status of the following clinical trial:

Trial Title: Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Over 18 years of age.~* R5 HIV infection on screening tropism test.~* Viral load \>1,000 copies/mL.~* Never previously treated with anti-HIV medicines.~Exclusion Criteria:~* Previously treated with anti-HIV medicines.~* Hepatitis B co-infection.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Single arm study of combivir and maraviroc for 48 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).